Vacsera, the Holding Company for Biological Products and Vaccines, is Egypt's national vaccine manufacturer and one of Africa's oldest producers of biological products. Founded in 1881 and headquartered in Giza, the governmental holding company produces human and veterinary vaccines, sera, blood derivatives, and biotechnological medicines.
It operates through subsidiaries focused on vaccines, blood products, and related items to support national health security and regional supply. In June 2026, Vacsera signed a technical assistance agreement with EIB Global for a feasibility study on a new multi-product vaccine facility, with the overall project estimated at approximately €50 million and potential exports to other African countries.
Also known as فاكسيرا, Holding Company for Biological Products and Vaccines SAE, and الشركة المصرية القابضة للمستحضرات الحيوية واللقاحات.
€750,000 technical assistance will fund feasibility and market studies for a ~€50m multi-product vaccine plant to boost local and regional supply and support African manufacturing goals.
